| ［1］ |
Li J, Li M, Chen Q, et al. Quality of life among patients with rosacea: an investigation of patients in China using two structured questionnaires［J］. J Eur Acad Dermatol Venereol, 2016, 30（10）: e98⁃e99. DOI: 10.1111/jdv.13341.
|
| ［2］ |
Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the national rosacea society expert com⁃mittee on the classification and staging of rosacea［J］. J Am Acad Dermatol, 2002, 46（4）: 584⁃587. DOI: 10.1067/mjd.2002. 120625.
|
| ［3］ |
郝飞, 宋志强, 钟华. 激素依赖性皮炎: 如何界定?［J］. 中华皮肤科杂志, 2013, 46（7）: 528⁃529. DOI: 10.3760/cma.j.issn.0412⁃4030.2013.07.025.
|
| ［4］ |
Misery L, Loser K, Ständer S. Sensitive skin［J］. J Eur Acad Dermatol Venereol, 2016, 30（Suppl 1）: 2⁃8. DOI: 10.1111/jdv. 13532.
|
| ［5］ |
Holmes AD, Steinhoff M. Integrative concepts of rosacea patho⁃physiology, clinical presentation and new therapeutics［J/OL］. Exp Dermatol, 2016. Version of record online Oct 9, 2016. DOI: 10.1111/exd.13143.
|
| ［6］ |
Turgut EA, Gurel MS, Koku AAE, et al. Demodex mites in acne rosacea: reflectance confocal microscopic study［J/OL］. Australas J Dermatol, 2016. Version of record online Mar 9, 2016. DOI: 10.1111/ajd.12452.
|
| ［7］ |
Murillo N, Aubert J, Raoult D. Microbiota of Demodex mites from rosacea patients and controls［J］. Microb Pathog, 2014, 71⁃72: 37⁃40. DOI: 10.1016/j.micpath.2014.04.002.
|
| ［8］ |
McMahon F, Banville N, Bergin DA, et al. Activation of neu⁃trophils via IP3 pathway following exposure to demodex⁃associated bacterial proteins［J］. Inflammation, 2016, 39（1）: 425⁃433. DOI: 10.1007/s10753⁃015⁃0264⁃4.
|
| ［9］ |
Drago F, De Col E, Agnoletti AF, et al. The role of small intestinal bacterial overgrowth in rosacea: a 3⁃year follow⁃up［J］. J Am Acad Dermatol, 2016, 75（3）: e113⁃115. DOI: 10.1016/j.jaad. 2016.01.059.
|
| ［10］ |
Ikizoglu G. Red face revisited: Flushing［J］. Clin Dermatol, 2014, 32（6）: 800⁃808. DOI: 10.1016/j.clindermatol.2014.02.019.
|
| ［11］ |
Steinhoff M, Schmelz M, Schauber J. Facial erythema of rosacea ⁃aetiology, different pathophysiologies and treatment options［J］. Acta Derm Venereol, 2016, 96（5）: 579⁃586. DOI: 10.2340/00015555⁃2335.
|
| ［12］ |
Zitelli KB, Sheil AT, Fleck R, et al. Idiopathic facial aseptic granuloma: review of an evolving clinical entity［J］. Pediatr Dermatol, 2015, 32（4）: e136⁃139. DOI: 10.1111/pde.12571.
|
| ［13］ |
Rainer BM, Fischer AH, Luz FdSD, et al. Rosacea is associated with chronic systemic diseases in a skin severity⁃dependent manner: results of a case⁃control study［J］. J Am Acad Dermatol, 2015, 73（4）: 604⁃608. DOI: 10.1016/j.jaad.2015.07.009.
|
| ［14］ |
Asai Y, Tan J, Baibergenova A, et al. Canadian clinical practice guidelines for rosacea［J］. J Cutan Med Surg, 2016, 20（5）: 432⁃445. DOI: 10.1177/1203475416650427.
|
| ［15］ |
Layton A, Thiboutot D. Emerging therapies in rosacea［J］. J Am Acad Dermatol, 2013, 69（6 Suppl 1）: S57⁃65. DOI: 10.1016/j.jaad.2013.04.041.
|
| ［16］ |
Di NA, Holmes AD, Muto Y, et al. Improved clinical outcome and biomarkers in adults with papulopustular rosacea treated with doxycycline modified⁃release capsules in a randomized trial［J］. J Am Acad Dermatol, 2016, 74（6）: 1086⁃1092. DOI: 10.1016/j.jaad.2016.01.023.
|
| ［17］ |
Sbidian E, Vicaut É, Chidiack H, et al. A randomized⁃controlled trial of oral low⁃dose isotretinoin for difficult⁃to⁃treat papulopu⁃stular rosacea［J］. J Invest Dermatol, 2016, 136（6）: 1124⁃1129. DOI: 10.1016/j.jid.2016.01.025.
|
| ［18］ |
Holmes AD, Waite KA, Chen MC, et al. Dermatological adverse events associated with topical brimonidine gel 0.33 in subjects with erythema of rosacea: a retrospective review of clinical studies［J］. J Clin Aesthet Dermatol, 2015, 8（8）: 29⁃35.
|
| ［19］ |
中国医师协会皮肤科医师分会皮肤美容亚专业委员会. 中国玫瑰痤疮诊疗专家共识（2016）［J］. 中华皮肤科杂志, 2017, 50（3）: 156-161. DOI: 10.3760/cma.j.issn.0412⁃4030.2017.03.002.
|
